State of Michigan Retirement System Has $18.11 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

State of Michigan Retirement System grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,309 shares of the company’s stock after buying an additional 100 shares during the period. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $18,114,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Sanders Capital LLC raised its holdings in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares during the period. Wellington Management Group LLP raised its holdings in HCA Healthcare by 1.7% during the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after buying an additional 170,560 shares during the period. Royal Bank of Canada increased its holdings in HCA Healthcare by 35.7% during the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after purchasing an additional 1,183,890 shares in the last quarter. Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $694,985,000. Finally, Morgan Stanley grew its stake in HCA Healthcare by 1.4% in the 3rd quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after buying an additional 30,072 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $319.70 on Wednesday. The firm has a market cap of $83.73 billion, a PE ratio of 15.94, a price-to-earnings-growth ratio of 1.49 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $344.20. The firm’s fifty day moving average is $326.06 and its 200-day moving average is $317.80. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. During the same period in the previous year, the firm earned $4.93 earnings per share. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. Sell-side analysts predict that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a dividend of $0.66 per share. The ex-dividend date was Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare’s dividend payout ratio is 13.16%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HCA. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday. TD Cowen dropped their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a report on Tuesday. Finally, Oppenheimer increased their price target on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $326.53.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,397 shares of company stock valued at $3,921,929. 1.70% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.